Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VINORELBINE\VINORELBINE Cause Second primary malignancy? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Second primary malignancy have been filed in association with VINORELBINE\VINORELBINE. This represents 0.4% of all adverse event reports for VINORELBINE\VINORELBINE.

6
Reports of Second primary malignancy with VINORELBINE\VINORELBINE
0.4%
of all VINORELBINE\VINORELBINE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Second primary malignancy From VINORELBINE\VINORELBINE?

Of the 6 reports, 2 (33.3%) required hospitalization.

Is Second primary malignancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VINORELBINE\VINORELBINE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does VINORELBINE\VINORELBINE Cause?

Malignant neoplasm progression (158) Neutropenia (151) Disease progression (105) Death (98) Off label use (94) Nausea (89) Anaemia (88) Drug ineffective (81) Diarrhoea (77) Vomiting (71)

What Other Drugs Cause Second primary malignancy?

CYCLOPHOSPHAMIDE (1,247) DOXORUBICIN (1,151) VINCRISTINE (908) IMATINIB (763) PALBOCICLIB (658) RITUXIMAB (646) RUXOLITINIB (611) ETOPOSIDE (573) PREDNISONE (517) OCTREOTIDE (496)

Which VINORELBINE\VINORELBINE Alternatives Have Lower Second primary malignancy Risk?

VINORELBINE\VINORELBINE vs VIREAD VINORELBINE\VINORELBINE vs VISIPAQUE VINORELBINE\VINORELBINE vs VISMODEGIB VINORELBINE\VINORELBINE vs VITAMIN A VINORELBINE\VINORELBINE vs VITAMIN B

Related Pages

VINORELBINE\VINORELBINE Full Profile All Second primary malignancy Reports All Drugs Causing Second primary malignancy VINORELBINE\VINORELBINE Demographics